Ortega A A - OmicsDI

Show results for

Unknown (5503)
Proteomics (89)
Transcriptomics (52)
Genomics (10)
Models (4)
Metabolomics (4)
Multiomics (3)
Other (2)

Organisms

Homo sapiens (63)
Mus musculus (31)
Escherichia coli (4)
Mycobacterium tuberculosis (3)
Equus caballus (3)
Rattus norvegicus (3)
Amphiura filiformis (2)
Gasterosteus aculeatus (2)
Bos taurus (2)
Anastrepha ludens (2)
Flavobacterium johnsoniae (2)
Quercus ilex (2)
Streptococcus pneumoniae (2)
Sus scrofa domesticus (2)
cellular organisms (1)
Platichthys flesus (1)
Microtus duodecimcostatus (1)
Canis lupus familiaris (1)
Pseudomonas aeruginosa (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)
572307 (1)
Alteromonas macleodii (1)
Bacillus subtilis subsp. subtilis str. 168 (1)
Bacteria (1)
Bacteroides cellulosilyticus (1)
Bacteroides thetaiotaomicron VPI-5482 (1)
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 (1)
Insecta (1)
Leishmania major strain Friedlin (1)

Organisms

Rattus norvegicus (1)

Repository

pride (81)
biostudies-arrayexpress (54)
MassIVE (8)
EGA (5)
BioModels (3)
MetaboLights (3)
ENA (3)
Cell Collective (1)
GNPS (1)
GPMDB (1)
iProX (1)

Tissue

Cell culture (16)
Blood (5)
Liver (5)
Blood plasma (4)
Brain (4)
Epithelial cell (4)
T cell (4)
B cell (3)
Blood cell (3)
Hepatocyte (3)
Kidney (3)
Permanent cell line cell (3)
Adrenal gland (2)
Antenna (2)
Blood serum (2)
Extracellular vesicle (2)
Hippocampus (2)
Leaf (2)
Lung (2)
Prokaryotic cell (2)
Sperm (2)
Abdominal aorta (1)
Bile (1)
Bone marrow-derived macrophage (1)
Cell suspension culture (1)
Colon (1)
Epithelial cell differentiation involved in embryonic placenta development (1)
Fibroblast (1)
Group 2 innate lymphoid cell (1)
Heart (1)

Disease

Breast cancer (3)
Intracerebral hemorrhage (3)
COVID-19 (2)
Colon cancer (2)
Melanoma (2)
Alzheimer's disease (1)
Adenocarcinoma (1)
Normal (1)
Not Available (1)
Abdominal aortic aneurysm (1)
Acute leukemia (1)
Chronic kidney disease (1)
Disease free (1)
Down syndrome (1)
Lung cancer (1)
Lymphoma (1)
Malignant neoplasm of ovary (1)
Mixed disorder as reaction to stress (1)
Multiple sclerosis (1)
Pancreatic ductal adenocarcinoma (1)
Pleural empyema (1)
Pleural empyema (1)
Pseudomyxoma peritonei (1)
Rheumatoid arthritis (1)
Stroke (1)
Substance abuse (1)

Technology Type

Mass Spectrometry (81)
Shotgun proteomics (42)
Bottom-up proteomics (10)
SWATH MS (8)
Data-dependent acquisition (7)
Affinity purification coupled with mass spectrometry proteomics (6)
Chemical cross-linking coupled with mass spectrometry proteomics (4)
Data-independent acquisition (4)
Gel-based experiment (4)
Top-down proteomics (4)
Mass spectrometry (3)
HDMSE (2)
Illumina_670k - Illuminus, Affymetrix 6.0, Illumina 1.2M (1)
MSE (1)
Mass spectrometry imaging (1)

Instrument Platform

Bruker maXis ESI Quadrupole TOF (2)
Orbitrap Eclipse (2)
Liquid Chromatography MS - negative - hilic (2)
MSI GP76 Leopard 10UE-060ES Intel Core i7-10870H/16GB/1TB SSD/RTX 3060/17.3\ (1)
Manual protocol (1)
Affymetrix GeneChip Scanner 3000 7G (1)
NextSeq 2000 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
Instrument (1)
Orbitrap Exploris 240 (1)
Orbitrap Fusion (1)
Q Exactive HF-X (1)
TimsTOF Pro (1)
TimsTOF Ultra (1)
ZenoTOF 7600 (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2023 (19)
2025 (17)
2024 (15)
2021 (15)
2015 (9)
2017 (8)
2022 (8)
2020 (8)
2014 (8)
2019 (7)
2016 (7)
2026 (5)
2013 (5)
2012 (4)
2010 (4)
2009 (3)
2008 (3)
2018 (3)
2011 (2)
2006 (1)

UNIPROT ID/AC

P05067 (1)

CHEBI ID

CHEBI:15354 (2)
CHEBI:16643 (2)
CHEBI:16828 (2)
CHEBI:18050 (2)
CHEBI:18344 (2)
CHEBI:16541 (1)
CHEBI:107736 (1)
CHEBI:111762 (1)
CHEBI:115196 (1)
CHEBI:124959 (1)
CHEBI:133086 (1)
CHEBI:135939 (1)
CHEBI:137790 (1)
CHEBI:137889 (1)
CHEBI:138375 (1)
CHEBI:140755 (1)
CHEBI:144643 (1)
CHEBI:145334 (1)
CHEBI:15603 (1)
CHEBI:15699 (1)
CHEBI:15724 (1)
CHEBI:15756 (1)
CHEBI:15815 (1)
CHEBI:15824 (1)
CHEBI:15891 (1)
CHEBI:15971 (1)
CHEBI:16010 (1)
CHEBI:16020 (1)
CHEBI:16040 (1)
CHEBI:16108 (1)

Metabolite Name

(3-Carboxypropyl)trimethylammonium cation (1)
1'-Hydroxymidazolam .beta.-D-glucuronide (1)
1,2-Dilinoleoyl-sn-glycero-3-phosphocholine (1)
1,2-Dipalmitoyl-sn-glycero-O-ethyl-3-phosphatidylcholine cation (1)
1,5-Pentanediamine (1)
1-Methyladenosine (1)
2-Lysophosphatidylcholine (1)
2-Mercaptobenzothiazole (1)
2-Methylbutyryl-L-carnitine (1)
3,5,9-Trioxa-4-phosphatetracosan-1-aminium, 7-(acetyloxy)-24-carboxy-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)- (1)
3-Hydroxybutyrylcarnitine (1)
4-Acetamidoantipyrin (1)
4-Acetamidobutanoate (1)
4-Formylaminoantipyrine (1)
4-hydroxy-2-quinolinecarboxylic acid (1)
5-oxoproline (1)
ACar 20:4 (1)
Acetaminophen sulfate (1)
Acetyl-L-carnitine (1)
Adipoyl-L-carnitine (1)
Azithromycin (1)
Benzylamine (1)
Bilirubin (1)
Bis(2-ethylhexyl) adipate (1)
Caffeine (1)
Carbamazepine (1)
Carbamazepine-10,11-epoxide (1)
Choline cation (1)
Clozapine (1)
Creatine (1)

First Public Date

2026 (1)
2025 (1)
2023 (1)

Modelling Approach

Ordinary differential equation model (2)
Logical model (1)

Lab affiliation

Instituto de Investigaciones Sanitarias de Santiago de Compostela (5)
King's College London (4)
Departamento de Medicina Animal, Hospital Clínico Veterinario Universidad de Extremadura Avd de la Universidad s/n 10003 Cáceres SPAIN (2)
Pacific Northwest National Laboratory, USA (2)
1 Garvan Institute of Medical Research and The Kinghorn Cancer Centre, 384 Victoria Street Darlinghurst Sydney, NSW, 2010, Australia. 2 St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Australia. (1)
1-Department of Biochemistry and Molecular Medicine; Université de Montréal; C.P. 6128, Succ. Centre-Ville, Montréal, Québec, H3C 3J7; Canada. 2-Institut de Recherches Cliniques de Montréal, 110 Avenue des Pins Ouest, Montréal, Québec, H2W 1R7; Canada. 3-Faculty of Medicine, Division of Experimental Medicine, McGill University, Montréal, Québec, H3A 1A3; Canada. (1)
Agroforestry and Plant Biochemistry, Proteomics and Systems Biology. Departament of Biochemistry and Molecular Biology. University of Cordoba. Spain (1)
Biochemistry and Molecular Biology and Michael Smith Laboratories, University of British Columbia, Canada (1)
Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Canada (1)
Biomedical Research in Melanoma-Animal Models and Cancer Laboratory Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Hospital Barcelona-UAB Barcelona, 08035, Spain. (1)
Biomedical Research in Melanoma-Animal Models and Cancer Laboratory- Vall d´Hebron Research Institute VHIR-Vall d’Hebron Hospital Barcelona-UAB 08035, Spain. (1)
Biozentrum, University of Basel, 4056 Basel, Switzerland (1)
CNIC (1)
CNIO (1)
Cardiovascular Proteomics Laboratory & Proteomics Unit Centro Nacional de Investigaciones Cardiovasculares Madrid, Spain (1)
Cell Signaling and Clinical Proteomics Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo (Spain) (1)
Departamento de Biología Celular, Biología Funcional y Antropología Física,Instituto de Biotecnología y Biomedicina (1)
Departamento de Bioquímica y Biología Molecular B e Inmunologia. Facultad de Química. Universidad de Murcia. Campus de Excelencia Mare Nostrum (1)
Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba; Campus de Excelencia Internacional CeiA3, 14071 Córdoba (Spain) (1)
Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, Republic of Korea; Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, Republic of Korea. (1)
Department of Biochemistry and Biology, UBC (1)
Department of Biochemistry and Molecular Biology. University of Córdoba (1)
Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM), (1)
Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, W12 0BZ, UK (1)
Department of Food Science and Technology, The Ohio State University, Columbus, OH, USA (1)
Department of Molecular Biomedicine, CINVESTAV-IPN (1)
Division of Protective Immunity Children’s Hospital of Philadelphia 816F ARC, 3615 Civic Center Boulevard Philadelphia, PA 19104 (1)
EDyP (1)
FDA (1)
Facultad de Estudios Superiores Iztacala, Unidad de Biomedicina, Universidad Nacional Autónoma de México, México (1)

IsPrivate

False (3)

Model Flag

Non Kinetic (1)

Study type

Transcription profiling by array (38)
RNA-seq of coding RNA (7)
Animal - High-throughput sequencing (2)
ChIP-seq (2)
MicroRNA profiling by array (2)
Human - Methylation microarray (1)
Cell line - One-color microarray (1)
Methylation profiling by array (1)

Release Date

2022 (743)
2023 (691)
2021 (668)
2025 (651)
2024 (554)
2020 (495)
2019 (342)
2018 (263)
2017 (229)
2016 (200)
2015 (162)
2014 (116)
2026 (92)
2013 (87)
2012 (68)
2011 (52)
2010 (47)
2009 (33)
2008 (31)
2006 (10)
2007 (9)
2005 (4)
2002 (4)
2004 (2)
2000 (2)
2001 (1)
1999 (1)

Previous page
1 / 567
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 567
Next page

Sort by:

Relevance

Page size

Antihyperalgesic and Antiallodynic Effects of Amarisolide A and Salvia amarissima Ortega in Experimental Fibromyalgia-Type Pain.

Not available

S-EPMC9863681 | biostudies-literature

Flavonoids and Terpenoids with PTP-1B Inhibitory Properties from the Infusion of Salvia amarissima Ortega.

Not available

S-EPMC7435600 | biostudies-literature

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

Not available

S-EPMC4319639 | biostudies-literature

A multi-approach assessment of land use effects on groundwater quality in a karstic aquifer.

Not available

S-EPMC7266785 | biostudies-literature

Ortega2013 - Interplay between secretases determines biphasic amyloid-beta level

Ortega2013 - Interplay between secretases determines biphasic amyloid-beta level This model is described in the article: Interplay between ?-, ?-, and ?-secretases determines biphasic amyloid-? protein level in the presence of a ?-secretase inhibitor. Ortega F, Stott J, Visser...

2024-09-02 | BIOMD0000000556 | BioModels

Two new genera of metalmark butterflies of North and Central America (Lepidoptera, Riodinidae).

Not available

S-EPMC5799793 | biostudies-literature

Accuracy of paper-and-pencil systematic observation versus computer-aided systems.

Not available

S-EPMC10027644 | biostudies-literature

Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.

Not available

S-EPMC6137451 | biostudies-literature

Development of a high-throughput (10 minute microflow gradient) platform for quantitation of histone modifications on a new QTOF instrument

Histone post-translational modifications (PTMs) regulate gene expression patterns through epigenetic mechanisms. The 5 histone proteins (H1, H2A, H2B, H3, and H4) are extensively modified, with over 75 distinct modification types spanning more than 200 sites. Despite strong advances in mass spectrom...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2024-05-06 | MSV000094696 | MassIVE

Development of a high-throughput (10 minute microflow gradient) platform for quantitation of histone modifications on a new QTOF instrument

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2024-05-06 | MSV000094695 | MassIVE

Previous page
1 / 567
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 567
Next page

Sort by:

Relevance

Page size

5664 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Model Flag

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets